Single-institution results of autologous bone marrow transplantation in acute myeloid leukemia

G. Lambertenghi Deliliers, C. Annaloro, A. Della Volpe, A. Oriani, R. Mozzana, E. Pozzoli, E. Tagliaferri, D. Soligo

Research output: Contribution to journalArticlepeer-review


Background. Current results of autologous bone marrow transplantation (ABMT) suggest that this procedure may prolong disease-free survival (DFS) in patients with acute myeloid leukemia (AML). Materials and Methods. Over the last ten years, 29 AML patients received unpurged autologous bone marrow (BM) after a conditioning regimen including Ara-C (3 g/m 2/12 h, days -9, -8), CTX (60 mg/kg/day, days -6, -5) and TBI (3.33 Gy/day, days -3 through -1). In 21 patients, ABMT was performed as late intensification after first CR. Eight more relapsing patients were autografted after the achievement of second CR. Results. Three patients died from transplant-related complications. In the remaining patients, mean times to WBC and platelet recovery were, respectively, 23 days (range 13-55) and 55 days (range 22-790). Follow-up for censored patients ranged from 1 to 20 months. Relapse occurred in 7 patients (5 in first and 2 in second CR). Overall 5-year DFS and event-free survival (EFS) chances were, respectively, 67.3% and 60%, with no statistically significant differences between first (DFS=67.3%, EFS=60.3%) and second CR (DFS=68.6%, EFS=60%). Discussion. Apart from obvious selection biases, our study suggests that outcome in first CR AML patients is improved by ABMT. Long-term DFS and EFS are clearly better than when conventional post-remission chemotherapies are used. The greater antileukemic potential of ABMT is further underlined by the results in patients autografted in second CR, when conventional chemotherapy is almost never curative.

Original languageEnglish
Pages (from-to)136-141
Number of pages6
Issue number2
Publication statusPublished - 1995


  • acute myeloid leukemia
  • autologous bone marrow transplantation

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Single-institution results of autologous bone marrow transplantation in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this